Based on the ORIC PHARMAC.INC.DL-0001 stock forecast from 0 analysts, the average analyst target price for ORIC PHARMAC.INC.DL-0001 is not available over the next 12 months. ORIC PHARMAC.INC.DL-0001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ORIC PHARMAC.INC.DL-0001 is Neutral, which is based on 2 positive signals and 2 negative signals. At the last closing, ORIC PHARMAC.INC.DL-0001’s stock price was EUR 7.85. ORIC PHARMAC.INC.DL-0001’s stock price has changed by +0.64% over the past week, -15.59% over the past month and -1.26% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for 4TZ:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
